School of Nursing and Midwifery, Griffith University, Brisbane, Queensland, Australia.
Department of Nursing, Faculty of Allied Health Sciences, University of Ruhuna, Galle, Sri Lanka.
J Ren Care. 2024 Dec;50(4):376-383. doi: 10.1111/jorc.12498. Epub 2024 May 26.
Several countries are experiencing challenges in maintaining standard haemodialysis services for people with kidney failure.
This study aimed to investigate the health profile of people receiving haemodialysis and to identify factors associated with interdialytic weight gain.
A cross-sectional study.
A total of 166 adults with kidney failure and receiving haemodialysis for at least 3 months were included.
A structured chart audit form collected, demographic and haemodialysis treatment characteristics, recent biochemical and haematological results, and prescribed treatment regimens from clinical records. Data were analysed descriptively. Odds ratios (OR) were calculated to identify independent risk factors for interdialytic weight gain.
Mean age was 52 years (SD = 12.5), over half were male (60.2%, n = 100), and most were receiving 4 h of haemodialysis once per week (87.3%, n = 145). Approximately half (51.8%, n = 86) had an interdialytic weight gain >2%. Being female (OR = 3.39; 95% CI, 1.51-7.61), increased comorbidities (OR = 1.50; 95% CI, 1.22-1.84) and having BMI outside of the normal range (overweight/obese [OR = 8.49; 95% CI, 3.58-20.13] or underweight [OR = 4.61; 95% CI, 1.39-15.31]) were independent risk factors for increased interdialytic weight gain.
Most patients were receiving 4 h of haemodialysis once per week although only modest alterations in potassium, phosphate, and fluid status were observed. Understanding the patient profile and predictors of interdialytic weight gain will inform the development of self-management interventions to optimise clinician support.
一些国家在维持肾衰竭患者的标准血液透析服务方面面临挑战。
本研究旨在调查接受血液透析患者的健康状况，并确定与透析间期体重增加相关的因素。
横断面研究。
共纳入 166 名接受血液透析至少 3 个月的成年肾衰竭患者。
使用结构化图表审核表从临床记录中收集人口统计学和血液透析治疗特征、近期生化和血液学结果以及规定的治疗方案。对数据进行描述性分析。计算比值比（OR）以确定透析间期体重增加的独立危险因素。
平均年龄为 52 岁（标准差 = 12.5），超过一半为男性（60.2%，n = 100），大多数患者每周接受 4 小时血液透析一次（87.3%，n = 145）。大约一半（51.8%，n = 86）的患者透析间期体重增加超过 2%。女性（OR = 3.39；95%置信区间，1.51-7.61）、合并症增多（OR = 1.50；95%置信区间，1.22-1.84）和体重指数超出正常范围（超重/肥胖[OR = 8.49；95%置信区间，3.58-20.13]或消瘦[OR = 4.61；95%置信区间，1.39-15.31]）是透析间期体重增加的独立危险因素。
尽管钾、磷和液体状态只有适度改变，但大多数患者每周接受 4 小时血液透析治疗。了解患者特征和透析间期体重增加的预测因素将为制定自我管理干预措施提供信息，以优化临床医生的支持。
